Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Waters' ($38; NYSE: WAT) shares weakened after several prominent drug companies announced that generic competition and a lack of new products will hurt 2002 results. Waters has ties to the pharmaceutical sector via its chromatography instruments, which are used to identify new drugs and assure the potency and purity of new pharmaceuticals. That's good news for Waters and should help lift the firm's bottom line at least 16% in 2002. Waters, trading at 26 times 2002 earnings estimates, is a top "buy."

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.